These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36828239)

  • 1. Tacrolimus and paclitaxel co-loaded O/O ointment without surfactant: Synergistic combinations for the treatment of psoriasis.
    Liu W; Pan W; Zou M; Jin S; Mi R; Cheng G; Piao H
    Eur J Pharm Biopharm; 2023 Apr; 185():28-43. PubMed ID: 36828239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Surfactant-Free O/O Paclitaxel Ointment for the Topical Treatment of Psoriasis.
    Yin X; Cao X; Li J; Cheng X; Cheng G; Zou M; Piao H
    AAPS PharmSciTech; 2019 Jun; 20(5):212. PubMed ID: 31165303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis.
    Jain A; Doppalapudi S; Domb AJ; Khan W
    J Control Release; 2016 Dec; 243():132-145. PubMed ID: 27725194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Clobetasol and Tacrolimus Treatments in an Imiquimod-Induced Psoriasis Rat Model.
    Guillaume P; Rupp T; Froget G; Goineau S
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
    Sathe P; Saka R; Kommineni N; Raza K; Khan W
    Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic effect of glycyrrhizic acid compound ointment on imiquimod-induced psoriasis-like disease in mice.
    Zhang Y; Wang Q; Sun S; Jiang L
    PLoS One; 2023; 18(8):e0290637. PubMed ID: 37643205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
    Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
    Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities.
    Wan T; Pan W; Long Y; Yu K; Liu S; Ruan W; Pan J; Qin M; Wu C; Xu Y
    Int J Nanomedicine; 2017; 12():1485-1497. PubMed ID: 28260894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dapagliflozin ointment on induced psoriasis in an experimental model.
    Al Bahadly WKY; Bdioui A; Al-Gazally M; Al-Saedi H; Salah SHB; Ramadhan M
    J Med Life; 2024 Mar; 17(3):281-285. PubMed ID: 39044933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus ointment is effective for facial and intertriginous psoriasis.
    Lebwohl M; Freeman AK; Chapman MS; Feldman SR; Hartle JE; Henning A;
    J Am Acad Dermatol; 2004 Nov; 51(5):723-30. PubMed ID: 15523350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus nanocrystals microneedle patch for plaque psoriasis.
    Men Z; Su T; Tang Z; Liang J; Shen T
    Int J Pharm; 2022 Nov; 627():122207. PubMed ID: 36122614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic anti-psoriatic effects of myeloid-derived suppressor cells in combination with systemic tacrolimus (FK-506) in an imiquimod-induced mouse model of psoriasis.
    Park MY; Choo YK; Jeon SH; Jang WG; Lee JH; Park JH; Kim CH
    Int Immunopharmacol; 2020 Sep; 86():106553. PubMed ID: 32563057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs.
    Lin YK; Yang SH; Chen CC; Kao HC; Fang JY
    PLoS One; 2015; 10(9):e0137890. PubMed ID: 26355594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study.
    De Simone C; Maiorino A; Tassone F; D'Agostino M; Caldarola G
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1003-6. PubMed ID: 22788697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus ointment improves psoriasis in a microplaque assay.
    Remitz A; Reitamo S; Erkko P; Granlund H; Lauerma AI
    Br J Dermatol; 1999 Jul; 141(1):103-7. PubMed ID: 10417522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low systemic exposure and calcemic effect of calcipotriol/betamethasone ointment in rats with imiquimod-induced psoriasis-like dermatitis.
    Satake K; Amano T; Okamoto T
    Eur J Pharmacol; 2018 May; 826():31-38. PubMed ID: 29476878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
    OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
    Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus-loaded chitosan nanoparticles for enhanced skin deposition and management of plaque psoriasis.
    Fereig SA; El-Zaafarany GM; Arafa MG; Abdel-Mottaleb MMA
    Carbohydr Polym; 2021 Sep; 268():118238. PubMed ID: 34127220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary study of the efficacy and tolerability of combination therapy with calcipotriene ointment 0.005% and tacrolimus ointment 0.1% in the treatment of stable plaque psoriasis.
    Tirado-Sánchez A; Ponce-Olivera RM
    Cutis; 2012 Sep; 90(3):140-4. PubMed ID: 23094314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality-by-Design Approach for Investigating the Efficacy of Tacrolimus and Hyaluronic Acid-Loaded Ethosomal Gel in Dermal Management of Psoriasis: In Vitro, Ex Vivo, and In Vivo Evaluation.
    Dadwal N; Amisha ; Singh D; Singh A
    AAPS PharmSciTech; 2023 Nov; 24(8):220. PubMed ID: 37914839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.